These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1548065)

  • 1. Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.
    Powles MA; McFadden DC; Pittarelli LA; Schmatz DM
    Infect Immun; 1992 Apr; 60(4):1397-400. PubMed ID: 1548065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of Pneumocystis carinii in various mouse strains using natural transmission to initiate infection.
    McFadden DC; Powles MA; Pittarelli LA; Schmatz DM
    J Protozool; 1991; 38(6):126S-127S. PubMed ID: 1818134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice.
    Walzer PD; Powell RD; Yoneda K
    Infect Immun; 1979 Jun; 24(3):939-47. PubMed ID: 313907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Pneumocystis carinii pneumonia in C3H/HeJ and C3HeB/FeJ mice.
    Walzer PD; Rutledge ME; Yoneda K
    J Reticuloendothel Soc; 1983 Jan; 33(1):1-9. PubMed ID: 6601189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts.
    Dumoulin A; Mazars E; Seguy N; Gargallo-Viola D; Vargas S; Cailliez JC; Aliouat EM; Wakefield AE; Dei-Cas E
    Eur J Clin Microbiol Infect Dis; 2000 Sep; 19(9):671-8. PubMed ID: 11057500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.
    Walzer PD; Rutledge ME
    Infect Immun; 1982 Feb; 35(2):620-6. PubMed ID: 6976938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice.
    Gigliotti F; Harmsen AG; Wright TW
    Infect Immun; 2003 Jul; 71(7):3852-6. PubMed ID: 12819069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of Pneumocystis carinii pneumonia in germ-free rats requires immunosuppression and exposure to the Pneumocystis carinii organism.
    Wolff L; Horch S; Gemsa D
    Comp Immunol Microbiol Infect Dis; 1993 Jan; 16(1):73-6. PubMed ID: 8440087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice.
    McFadden DC; Powles MA; Smith JG; Flattery AM; Bartizal K; Schmatz DM
    Infect Immun; 1994 Nov; 62(11):4887-92. PubMed ID: 7927769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on placental transmission of Pneumocystis carinii in mice using immunodeficient SCID mice as a new animal model.
    Ito M; Tsugane T; Kobayashi K; Kuramochi T; Hioki K; Furuta T; Nomura T
    J Protozool; 1991; 38(6):218S-219S. PubMed ID: 1818176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoculated mouse model of Pneumocystis carinii pneumonia.
    Bartlett MS; Queener SF; Durkin MM; Shaw MM; Smith JW
    J Protozool; 1991; 38(6):130S-131S. PubMed ID: 1818136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis carinii is not universally transmissible between mammalian species.
    Gigliotti F; Harmsen AG; Haidaris CG; Haidaris PJ
    Infect Immun; 1993 Jul; 61(7):2886-90. PubMed ID: 8514391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity of Pneumocystis carinii derived from infected rats, mice, ferrets, and cell cultures.
    Weinberg GA; Durant PJ
    J Eukaryot Microbiol; 1994; 41(3):223-8. PubMed ID: 8049685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response.
    An CL; Gigliotti F; Harmsen AG
    Infect Immun; 2003 Apr; 71(4):2065-70. PubMed ID: 12654827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.
    Bartlett MS; Current WL; Orazi A; Bauer NL; Neiman RS; Queener SF; Smith JW
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):511-6. PubMed ID: 8556494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to Pneumocystis carinii protects rats and mice from developing pneumonia.
    Bartlett MS; Angus WC; Shaw MM; Durant PJ; Lee CH; Pascale JM; Smith JW
    Clin Diagn Lab Immunol; 1998 Jan; 5(1):74-7. PubMed ID: 9455884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.
    Walzer PD; Runck J; Steele P; White M; Linke MJ; Sidman CL
    Antimicrob Agents Chemother; 1997 Feb; 41(2):251-8. PubMed ID: 9021175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and inter-species transmission and antigenic difference of Pneumocystis carinii derived from rat and mouse.
    Furuta T; Ueda K
    Jpn J Exp Med; 1987 Feb; 57(1):11-7. PubMed ID: 3306057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural mode of acquisition for de novo infection with Pneumocystis carinii.
    Hughes WT
    J Infect Dis; 1982 Jun; 145(6):842-8. PubMed ID: 6979590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.